Ignite Creation Date:
2024-05-06 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05272371
Status:
RECRUITING
Last Update Posted:
2022-03-09
First Post:
2022-03-01
Brief Title:
Immunotherapy With Dinutuximab Beta in Combination With Chemotherapy for the Treatment of Patients With Primary Neuroblastoma Refractory to Standard Therapy and With Relapsed or Progressive Disease
Sponsor:
Organization:
Jagiellonian University